EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy

Chang Gung Medical Foundation

Status: Unknown

Conditions: Mediastinal Lymphadenopathy; Lung Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01493739

EBUSTBNA_01

Details and patient eligibility

About

This study aims on the combinatorial results of cytology, histopathology and microbiology obatined by EBUS-TBNA for unselected mediastina lesions.

Full description

A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness is far less. This study primarily focusing on merged approach of cytology, histopathology and microbioloogy obatined by EBUS-TBNA for unselected mediastina lesions.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years old
• mediastinal lymphadenopathy on Chest CT scan
• with a short-axis > 10mm

Exclusion criteria

• patients intolerant to bronchoscopy exam
• unstable vital sign (Blood pressure, heart rate, breath rate)

Trial design

100 participants in 1 patient group

lymphadenopathy